| Rutgers Cancer Institute

Rutgers Cancer Institute and its Top Research Leader Dr. Eileen White Selected to Lead Global Cancer Grand Challenges Team Taking on Cancer Cachexia

Rutgers-led Team Given $25 Million to Study Cancer Cachexia

Rutgers Cancer Institute’s Dr. Eileen White leads global CANCAN team with Cold Spring Harbor Laboratory and Weill Cornell Medicine to address late-stage cancer condition.

Read more about White CGC Grant 062022

Sign Up for MyChart

MyChart personal health record lets you manage your care from your computer or mobile device. LEARN MORE

Read more about MyChart Rotator

Presentations by Rutgers Cancer Institute/ RWJBarnabas Health Physicians at the 2022 ASCO Annual Meeting

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Expansive, Diverse and Compelling New Cancer Research at the 2022 ASCO Annual Meeting
Read press release here

Read more about Presentations by Rutgers Cancer Institute/ RWJBarnabas Health Physicians at the 2022 ASCO Annual Meeting

June 2022 Support Group Calendar

Read more about June 2022 Support Group Calendar

Welcoming the New Chief of Bone Marrow Transplant and Cellular Therapies

Ira Braunschweig, MD, has been appointed as chief, Section of Transplant and Cell Therapy at Rutgers Cancer Institute, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas facility.

Read more about Welcome Dr. Braunschweig

PRide Month 2022

Addressing the Unique Needs of LGBTQ+ Cancer Patients

While we celebrate the diversity, strength, and resilience of the LGBTQ+ community, we must also call attention to unique needs and challenges of these individuals who are faced with cancer. Read more